(Q35547252)

8 August 2017

1 reference

title

Haematopoietic stem cell transplantation for the treatment of systemic sclerosis and other autoimmune disorders (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

16 March 2024

author

Marco Matucci-Cerinic

2

object named as

Marco Matucci-Cerinic

0 references

author name string

Alan Tyndall

1

1 reference

PubMed ID

14519069

8 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

PubMed ID

14519069

full work available at URL

8 August 2017

http://www.tandfonline.com/doi/pdf/10.1517/14712598.3.7.1041

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

Expert Opinion on Biological Therapy

16 March 2024

published in

1 reference

8 August 2017

3

1 reference

8 August 2017

7

1 reference

8 August 2017

1041-1049

1 reference

Immunopathogenesis of systemic sclerosis

8 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Pathogenesis of scleroderma. Collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Autoimmune thrombocytopenia acquired from an allogeneic bone-marrow graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): successful outcome in the recipient and induction of an SLE flare in the donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Stem cell transplantation in experimental models of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Treatment of autoimmune diseases by hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Autologous stem cell transplantation in the treatment of refractory rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Intense immunosuppression followed by purified blood CD34+ cell autografting in a patient with refractory juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Autologous stem cell transplantation in a case of treatment resistant central nervous system lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Relapse of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Stem cells engineered to express self-antigen to treat autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.7.1041

Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review

16 March 2024

7

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation

16 March 2024

14

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

Stem cell transplantation for autoimmune diseases

16 March 2024

19

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis

16 March 2024

23

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis

16 March 2024

24

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy

16 March 2024

27

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis

16 March 2024

29

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

Prolonged remission state of refractory adult onset Still's disease following CD34-selected autologous peripheral blood stem cell transplantation

16 March 2024

30

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

Haemopoietic stem-cell transplantation for juvenile chronic arthritis

16 March 2024

32

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

Marked and sustained improvement 2 years after autologous stem cell transplantation in a girl with systemic sclerosis

16 March 2024

35

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration

16 March 2024

37

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

Control of severe systemic lupus erythematosus after high-dose immunusuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood

16 March 2024

39

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus

16 March 2024

43

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

Autologous peripheral blood stem cell transplantation in a patient with severe mixed connective tissue disease

16 March 2024

46

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

Autologous stem cell transplantation for rapidly progressive Jo-1-positive polymyositis with long-term follow-up

16 March 2024

48

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients

16 March 2024

49

1 reference

https://api.crossref.org/works/10.1517/14712598.3.7.1041

16 March 2024

Identifiers

1 reference

8 August 2017

1 reference

PubMed ID

14519069